For a disease afflicting 35.5 million people in the U.S., chronic kidney disease flies under the radar. Only half the people ...

Chronic Kidney Disease (CKD) affects approximately 15% of U.S. adults and as many as 9 in 10 with CKD are unaware they have ...

Research led by Children's Hospital of Fudan University in China has found that a gene called pancreatic progenitor cell ...

Deficiency of the pancreatic progenitor cell differentiation and proliferation factor gene was identified as a risk factor ...

In patients with heart failure with preserved ejection fraction and obesity, tirzepatide improved clinical outcomes compared ...

Results from the SUMMIT trial suggest that tirzepatide is as effective in preventing heart failure events in those with ...

In the SOUL trial, Rybelsus produced a 14% risk reduction of major adverse cardiovascular events in patients with type 2 ...

Chronic Kidney Disease (CKD) is a widespread and frequently under recognised condition impacting millions around the globe.

Kidney Health New Zealand says a simple, $12 test could prevent hundreds of people languishing on waitlists for a kidney ...

The drug tirzepatide improved kidney function and cardiovascular outcomes among patients with obesity and heart failure with preserved ejection fraction (HFpEF) compared with placebo at one year, ...

A new study led by Dr. Hilla Chen from the Koret School of Veterinary Medicine at Hebrew University, recently published in ...

In March 2025, Shandong Suncadia Medicine Co., Ltd. conducted a phase II Clinical Study of Efficacy and Safety of HRS-1780 ...